0001572426-15-000048.txt : 20150520 0001572426-15-000048.hdr.sgml : 20150520 20150520182946 ACCESSION NUMBER: 0001572426-15-000048 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150518 FILED AS OF DATE: 20150520 DATE AS OF CHANGE: 20150520 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nexvet Biopharma plc CENTRAL INDEX KEY: 0001618561 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: NATL INST FOR BIOPROCESSING RESEARCH STREET 2: FOSTERS AVENUE, MOUNT MERRION CITY: BLACKROCK CO. DUBLIN STATE: L2 ZIP: 00000 BUSINESS PHONE: 353 1 215 8100 MAIL ADDRESS: STREET 1: NATL INST FOR BIOPROCESSING RESEARCH STREET 2: FOSTERS AVENUE, MOUNT MERRION CITY: BLACKROCK CO. DUBLIN STATE: L2 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: NEXVET BIOPHARMA Ltd DATE OF NAME CHANGE: 20140903 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PAYNE JOHN BERNARD CENTRAL INDEX KEY: 0001582392 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36828 FILM NUMBER: 15880820 MAIL ADDRESS: STREET 1: 9900 NE 114TH CIRCLE CITY: VANCOUVER STATE: WA ZIP: 98662 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2015-05-18 0001618561 Nexvet Biopharma plc NVET 0001582392 PAYNE JOHN BERNARD C/O NEXVET BIOPHARMA PLC NIBRT; FOSTERS AVENUE, MOUNT MERRION BLACKROCK L2 IRELAND 1 0 0 0 Ordinary Shares 2015-05-18 4 M 0 900 .125 A 2700 D Ordinary Shares 6195 I John Payne <John B. Payne Living A/C> Restricted Stock Units .125 2015-05-18 4 M 0 900 0 D 2015-03-31 2019-07-01 Ordinary Shares 900 900 D The reporting person has sole voting and dispositive power with respect to these reported securities. 50% of the Restricted Share Units vested and became convertible on 3/31/15, and the remaining 50% shall vest and become convertible on 6/30/15, in each case subject to payment of the nominal value per share to Issuer within 30 days of vesting. /s/ John Payne by Geraldine T. Farrell, Attorney-in-Fact 2015-05-20